KWALITY PHARMACEUTICALS
|
The Current P/E Ratio of KWALITY PHARMACEUTICALS is 24.70.
Share Price | ₹702.0 | Feb 11,2025 |
Market Cap | ₹730.1 Cr | |
Earnings-TTM | ₹29.6 Cr | TTM-Consolidated Results |
Price/Earnings | 24.70x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of KWALITY PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹730.1 Cr] as on Feb 11,2025
(/) Earnings [ ₹29.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 24.70x ]
Thus, for KWALITY PHARMACEUTICALS , the investors are currently willing to pay 24.70 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KWALITY PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of KWALITY PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of KWALITY PHARMACEUTICALS
PE Ratio Performance Analysis for KWALITY PHARMACEUTICALS
- KWALITY PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 9.27x.
- KWALITY PHARMACEUTICALS 's operated at median p/e ratio of 5.02x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KWALITY PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 17.85x.
- KWALITY PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 3.19x.
How does KWALITY PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
KWALITY PHARMACEUTICALS | 29.56 | 24.70 | 730.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.51 | 407,827.0 |
CIPLA LTD | 5,000.43 | 23.46 | 117,322.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.63 | 101,116.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 20.64 | 94,752.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 76.41 | 157,931.0 |
MANKIND PHARMA LTD | 2,050.73 | 49.32 | 101,137.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 56.44 | 105,086.0 |
LUPIN LTD | 2,651.94 | 35.57 | 94,327.2 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.03 | 66,606.3 |
ABBOTT INDIA LTD | 1,334.46 | 46.40 | 61,914.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KWALITY PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.63x |
Max industry PE | 76.41x |
Median industry PE | 35.51x |
Average industry PE | 36.92x |
You may also like the below Video Courses